Estrogen receptor polymorphisms: Significance to human physiology, disease and therapy

Recent Patents on DNA and Gene Sequences

Volumn 3, Issue 3, 2009, Pages 164-171

  Figtree, Gemma A ^a   Noonan, Jonathon E ^a   Bhindi, Ravinay ^a   Collins, Peter ^b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Estrogen; Patents; Pharmacogenetics; Polymorphism

Indexed keywords

APOLIPOPROTEIN E; CALCIUM; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT; TAMOXIFEN; VITAMIN D; VITAMIN D RECEPTOR;

ATHEROSCLEROSIS; BREAST CANCER; CARDIOVASCULAR DISEASE; CHROMOSOME 14; CHROMOSOME 6; DIAGNOSTIC VALUE; DYSLIPIDEMIA; ESTROGEN RESPONSIVE ELEMENT; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HORMONE SUBSTITUTION; HUMAN; MIGRAINE; OSTEOPOROSIS; PHARMACOGENETICS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; TREATMENT RESPONSE;

ANIMALS; BIOETHICAL ISSUES; ESTROGENS; HORMONE REPLACEMENT THERAPY; HUMANS; PATENTS AS TOPIC; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN;

EID: 70449570988     PISSN: 18722156     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221509789318397     Document Type: Review

References (94)

1. Green S. Walter P, Kumar V, et al. Human oestrogen receptor cDNA: sequence, expression and homology to v- erb-A. Nature 1986; 320: 134-139. (Pubitemid 16105150)
2. Kuiper GG, Enmark E, Pelto-Huikko M, et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93: 5925-5930. (Pubitemid 26190778)
3. Chambliss KL, Yuhanna IS, Mineo C, et al. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 2000; 87: E44-E52.
4. Chen Z, Yuhanna IS, Galcheva-Gargova Z, et al. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999; 103: 401-406. (Pubitemid 29069990)
5. Stefano GB, Prevot V, Beauvillain JC, et al. Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation 2000; 101: 1594-1597. (Pubitemid 30180897)
6. Kim HP, Lee JY, Jeong JK, et al. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae. Biochem Biophys Res Commun 1999; 263: 257-262.
7. Figtree GA, McDonald D, Watkins H, et al. Truncated estrogen receptor α 46-kDa isoform in human endothelial cells: Relationship to acute activation of nitric oxide synthase. Circulation 2003; 107: 120-126. (Pubitemid 36070943)
8. Haynes MP, Sinha D, Russell KS, et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-Kinase-Akt pathway in human endothelial cells. Circ Res 2000; 87: 677-682.
9. Simoncini T, Hafezi-Moghadam A, Brazil DP, et al. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000; 407: 538-541. (Pubitemid 30746711)
10. Couse JF, Lindzey J, Grandien K, et al. Tissue distribution and quantitative analysis of estrogen receptor α and estrogen receptor-β messenger ribonucleic acid in the wild-type and ER{alpha}-Knockout Mouse. Endocrinology 1997; 138: 4613-4621. (Pubitemid 27460895)
11. Yaghmaie F, Saeed O, Garan SA, et al. Caloric restriction reduces cell loss and maintains estrogen receptor-α immuno-reactivity in the pre-optic hypothalamus of female B6D2F1 mice. Neuro Endocrinol Lett 2005; 26: 197-203. (Pubitemid 40975096)
12. Takeyama J, Suzuki T, Inoue S, et al. Expression and cellular localization of estrogen receptors α and β in the human fetus. J Clin Endocr Metab 2001; 86: 2258-2262. (Pubitemid 32472949)
13. Bord S, Horner A, Beavan S, et al. Estrogen receptors α and β are differentially expressed in developing human bone. J Clin Endocrinol Metab 2001; 86: 2309-2314. (Pubitemid 32472956)
14. Eriksen EF, Colvard DS, Berg NJ, et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988; 241: 84-86.
15. Behl C. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 2002; 3: 433-442.
16. Venkov CD, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells: a potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996; 94: 727-733.
17. Hodges YK, Tung L, Yan XD, et al. Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation 2001; 101: 1792-1798. (Pubitemid 30213100)
18. Jayachandran M, Miller VM. Ovariectomy upregulates expression of estrogen receptors, NOS, and HSPs in porcine platelets. Am J Physiol Heart Circ Physiol 2002; 283: H220-226. (Pubitemid 34705343)
19. Flouriot G, Griffin C, Kenealy M, et al. Differentially expressed messenger RNA isoforms of the human estrogen receptor-alpha gene are generated by alternative splicing and promoter usage. Mol Endocrinol 1998; 12: 1939-1954. (Pubitemid 28544188)
20. Koritnik DR, Koshy A, Hoversland RC. 17 beta-estradiol treatment increases the levels of estrogen receptor and its mRNA in male rat liver. Steroids 1995; 60: 519-529.
21. Stavreus-Evers A, Parini P, Freyschuss B, et al. Estrogenic influence on the regulation of hepatic estrogen receptor-α and serum level of angiotensinogen in female rats. J Steroid Biochem Mol Biol 2001; 78: 83-88. (Pubitemid 32786790)
22. Freyschuss B, Sahlin L, Masironi B, et al. The hormonal regulation of the oestrogen receptor in rat liver: An interplay involving growth hormone, thyroid hormones and glucocorticoids. J Endocrinol 1994; 142: 285-298. (Pubitemid 24261503)
23. Davis VL, Chan CC, Schoen TJ, et al. An estrogen receptor repressor induces cataract formation in transgenic mice. Proc Nat Acad Sci USA 2002; 99: 9427-9432.
24. Shim GJ, Kis LL, Warner M, et al. Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor ?? gene. Proc Nat Acad Sci USA 2004; 101: 1720-1724. (Pubitemid 38236168)
25. Ponglikitmongkol M, Green S, Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO J 1988; 7: 3385-3388.
26. Grandien K, Backdahl M, Ljunggren O, et al. Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines. Endocrinology 1995; 136: 2223-2229.
27. Mosselman S, Polman J, Dijkema R. ER β: Identification and characterization of a novel human estrogen receptor. FEBS Lett 1996; 392: 49-53.
28. Sand P, Luckhaus C, Schlurmann K, et al. Untangling the human estrogen receptor gene structure. J Neural Transm 2002; 109: 567-583. (Pubitemid 34810757)
29. Enmark E, Pelto-Huikko M, Grandien K, et al. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997; 82: 4258-4265. (Pubitemid 27525550)
30. Enmark E, Gustafsson JA. Oestrogen receptors - an overview. J Intern Med 1999; 246: 133-138.
31. Critchley HO, Brenner RM, Henderson TA, et al. Estrogen receptor β, but not estrogen receptor α, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab 2001; 86: 1370-1378.
32. Lindner V, Kim SK, Karas RH, et al. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res 1998; 83: 224-229. (Pubitemid 28354468)
33. Hirata S, Shoda T, Kato J, et al. The multiple untranslated first exons system of the human estrogen receptor β gene. J Steroid Biochem Mol Biol 2001; 78: 33-40. (Pubitemid 32791329)
34. Korach KS. Insights from the study of animals lacking functional estrogen receptor. Science 1994; 266: 1524-1527.
35. Couse JF, Curtis HS, Korach KS. Receptor null mice reveal contrasting roles for estrogen receptor α and β in reproductive tissues. J Steroid Biochem Mol Biol 2000; 74: 287-296. (Pubitemid 32126241)
36. Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999; 20: 358-417.
37. Vidal O, Lindberg MK, Hollberg K, et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci USA 2000; 97: 5474-5479. (Pubitemid 30313743)
38. Windahl SH, Vidal O, Andersson G, et al. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERβ(-/-) mice. J Clin Invest 1999; 104: 895-901. (Pubitemid 29536339)
39. Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331: 1056-1061. (Pubitemid 24317698)
40. Sudhir K, Chou TM, Chatterjee K, et al. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 1997; 96: 3774-3777. (Pubitemid 27513460)
41. Chakravarti A. Population genetics - making sense out of sequence. Nat Genet; 1999. 21: 56-60.
42. Collins A, Lonjou C, Morton NE. Genetic epidemiology of single-nucleotide polymorphisms. Proc Natl Acad Sci USA 1999; 96: 15173-15177.
43. Andersen TI, Heimdal KR, Skrede M, et al. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet 1994; 94: 665-670. (Pubitemid 24351525)
44. Parl FF, Cavener DR, Dupont WD. Genomic DNA analysis of the estrogen receptor gene in breast cancer. Breast Cancer Res Treat 1989; 14: 57-64. (Pubitemid 20023424)
45. Ashton KA, Proietto A, Otton G, et al. Estrogen receptor polymorphisms and the risk of endometrial cancer. BJOG 2009; 116: 1053-1061.
46. Weel AE, Uitterlinden AG, Westendorp IC, et al. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 1999; 84: 3146-3150.
47. Colson NJ, Lea RA, Quinlan S, et al. The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics 2004; 5: 129-133. (Pubitemid 38828673)
48. Kobayashi S, Inoue S, Hosoi T, et al. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 1996 11: 306-311. (Pubitemid 26076380)
49. Sano M, Inoue S, Hosoi T, et al. Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 1995; 217: 378-383. (Pubitemid 26060487)
50. Deng HW, Li J, Li JL, et al. Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes. Hum Genet 1998; 103: 576-585. (Pubitemid 28548480)
51. Han K, Choi J, Moon I, et al. Non-association of estrogen receptor genotypes with bone mineral density and bone turnover in Korean pre-, peri-, and postmenopausal women. Osteoporos Int 1999; 9: 290-295. (Pubitemid 29216762)
52. Deng HW, Li J, Li JL, et al. Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women. J Clin Endocrinol Metab 2000; 85: 2748-2751. (Pubitemid 32269146)
53. Goulart AC, Zee RY, Rexrode KM. Estrogen receptor 1 gene polymorphisms and decreased risk of obesity in women. Metabolism 2009; 58: 759-764.
54. Kikuchi T, Hashimoto N, Kawasaki T, et al. Association of serum low-density lipoprotein metabolism with oestrogen receptor gene polymorphisms in healthy children. Acta Paediatr 2000; 89: 42-45. (Pubitemid 30060628)
55. Matsubara Y, Murata M, Kawano K, et al. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol 1997; 17: 3006-3012. (Pubitemid 28016053)
56. Kunnas TA, Laippala P, Penttila A, et al. Association of polymorphism of human α oestrogen receptor gene with coronary artery disease in men: a necropsy study. BMJ 2000; 321: 273-274. (Pubitemid 30487465)
57. Lu H, Higashikata T, Inazu A, et al. Association of estrogen receptor-α gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2002; 22: 817-823. (Pubitemid 34517795)
58. Herrington DM, Howard TD, Hawkins GA, et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 2002; 346: 967-974.
59. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group [see comments]. JAMA 1998; 280: 605-613.
60. Figtree GA, Kindmark A, Lind L, et al. Novel estrogen receptor alpha promoter polymorphism increases ventricular response to hypertension. J Steroid Biochem Mol Biol 2007; 103 110-118. (Pubitemid 46149299)
61. Penolazzi L, Lambertini E, Aguiari G, et al. Cis element 'decoy' against the upstream promoter of the human estrogen receptor gene. Biochim Biophys Acta 2000; 1492: 560-567.
62. Figtree GA, Guzik T, Robinson BG, et al. Functional estrogen receptor alpha promoter polymorphism is associated with improved endothelial-dependent vasolidation. Int J Cardiol 2009; [Epub Jan 19].
63. Figtree GA, Grieve SM, Speller B, et al. A commonly occurring polymorphism upstream of the estrogen receptor α alters transcription and is associated with increased HDL. Atherosclerosis 2008; 199: 354-361.
64. Shearman AM, Karasik D, Gruenthal KM, et al. Estrogen receptor β polymorphisms are associated with bone mass in women and men: the Framingham Study. J Bone Miner Res 2004; 19: 773-781. (Pubitemid 41094389)
65. Rivadeneira F, Meurs JB, Kant J, et al. Estrogen receptor β (ESR2) polymorphisms in interaction with estrogen receptor α (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. J Bone Miner Res 2006; 21: 1443-1456. (Pubitemid 44300051)
66. Gennari L, Becherini L, Falchetti A, et al. Genetics of osteoporosis: Role of steroid hormone receptor gene polymorphisms. J Steroid Biochem Mol Biol 2002; 81: 1-24. (Pubitemid 34785919)
67. Nott SL, Huang Y, Fluharty BR, et al. Do estrogen receptor β polymorphisms play a role in the pharmacogenetics of estrogen signaling? Curr Pharmacogenomics Person Med 2008; 6: 239-259.
68. Lau HH, Ho AY, Luk KD, et al. Estrogen receptor β gene polymorphisms are associated with higher bone mineral density in premenopausal, but not postmenopausal southern Chinese women. Bone 2002; 31: 276-281.
69. Wang Z, Yoshida S, Negoro K, et al. Polymorphisms in the estrogen receptor β gene but not estrogen receptor α gene affect the risk of developing endometriosis in a Japanese population. Fertil Steril 2004; 81: 1650-1656. (Pubitemid 38749012)
70. Peter I, Shearman AM, Zucker DR, et al. Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens 2005; 23: 2193-2200. (Pubitemid 41666749)
71. Mansur AP, Nogueira CC, Strunz CM, et al. Genetic polymorphisms of estrogen receptors in patients with premature coronary artery disease. Arch Med Res 2005; 36: 511-517. (Pubitemid 41140058)
72. Dresner-Pollak R, Kinnar T, Friedlander Y, et al. Estrogen receptor β gene variant is associated with vascular dementia in elderly women. Genet Test Mol Biomarkers 2009; 13: 339-342.
73. Sundarrajan C, Liao WX, Roy AC, et al. Association between estrogen receptor-β gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab 2001; 86: 135-139. (Pubitemid 32109786)
74. Goulart AC, Zee RY, Rexrode KM. Association of estrogen receptor 2 gene polymorphisms with obesity in women. Maturitas 2009; 62: 179-183.
75. Kalush, F., Cassel, M. J., Hwang, S. S.: WO03018746 (2003).
76. Kalush, F., Cassel, M. J., Hwang, S. S.: WO0234945 (2002).
77. Kalush, F., Cassel, M. J., Hwang, S. S.: WO0162793 (2001).
78. Rousseau, F.: WO9727321 (1997).
79. Kobayashi, S., Orimo, H., Ouchi, Y.: JP8214899 (1996).
80. Griffiths, L. R., Colson, N. J., Lea, R. A.: WO2005026385 (2005).
81. Wirtz, R., Hennig, G., Von Toerne, C.: WO2009068409 (2009).
82. Shiraki, M., Ouchi, Y., Hosoi, T.: JP2001333799 (2001).
83. Mugglestone, C. J.: WO2006091092 (2006).
84. Leskelae, H., Lehenkari, P. P., Kangas, L.: WO2006084937 (2006).
85. Herrington, D. M., Howard, T. D., Hawkins, G. A.: US2002187495 (2002).
86. Thomas SM, Hopkins MM, Brady M. Shares in the human genome - the future of patenting DNA. Nat Biotech 2008; 20: 1185-1188.
87. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001; 2: 91-99. (Pubitemid 33674000)
88. Bioethics NC. The Ethics of Patenting DNA. Nuffield Council on Bioethics: London 2002.
89. Figtree GA, Robinson BG, Channon KM, et al. Polymorphism upstream of estrogen receptor alpha reverses negative regulation of transcription. Int J Cardiol 2009; [Epub Jan 20].
90. Jazaeri O, Shupnik MA, Jazaeri AA, et al. Expression of estrogen receptor α mRNA and protein variants in human endometrial carcinoma. Gynecol Oncol 1999; 74: 38-47 (Pubitemid 29331165)
91. Ogata, T., Kamatani, N., Hasegawa, T.: JP2006061128 (2006).
92. Kusaba, N., Baba, T., Yoshida, H.: JP2001333798 (2001).
93. Kusaba, N., Baba, T., Yoshida, H.: JP2001029088 (2001).
94. Kusaba, N., Baba, T., Yoshida, H.: JP2000300295 (2000).